michaels resignation, page-4

I got out of BOS a while back - got sick of no real progress towards commercialising anything - but have continued to watch from the sidelines.

The compound applications work well in the controlled environment in the lab but when it comes to the "real world", they just can't get it to work. Contact lenses are the prime example. This company has great potential but its playing out like thats all it will ever have. Perhaps Michael also had this feeling?

Very disappointing...